BSE filing, NSE: BOMOXY-B1. Summary written from the filing by ALFA Finder's alert engine.
Bombay Oxygen Investments Ltd: key numbers
- Share price
- ₹16,700.00
- Market cap
- ₹250.5 Cr
- Revenue (annual)
- ₹-1.96 Cr
- Net profit (annual)
- ₹-3.24 Cr
- P/E (TTM)
- 238.6×Sector 19.7×
- Promoter holding
- 73.29%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bombay Oxygen Investments Ltd
All →Bombay Oxygen Investments Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is in compliance with SEBI listing regulations.
Bombay Oxygen Investments Annual General Meeting
Bombay Oxygen Investments Limited conducted its 65th Annual General Meeting on August 25, 2026. Shareholders considered the adoption of financial statements and the declaration of a dividend.
Bombay Oxygen Investments Regulatory Approval
Bombay Oxygen Investments is applying to the RBI for voluntary surrender of its NBFC Certificate of Registration. The company will continue operations as an unregistered NBFC.
Bombay Oxygen Investments Other Announcement
Bombay Oxygen Investments Ltd will apply to the RBI to voluntarily surrender its NBFC Certificate of Registration. The company expects no material impact on business operations.
Bombay Oxygen Investments Q1 FY27 Results: Net Profit ₹28.5 Cr, Up 17.8% YoY
Bombay Oxygen Investments Ltd reported revenue from operations of ₹33.6 Cr (+16.3% YoY) and net profit of ₹28.5 Cr (+17.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹28.5 Cr · +17.8% YoY
Bombay Oxygen Investments Board Meeting Date
Bombay Oxygen Investments Ltd has scheduled a board meeting for August 10, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.
RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.